Summary

Description (Web site quote)

SIL has a bank of more than 100 lines including 20 lines with genetic or chromosomal abnormalities.
The company is closely affiliated with the Reproductive Genetics Institute (RGI of Chicago, USA) – world leader in Preimplantation Genetic Diagnosis (PGD). SIL capitalizes on the great experience of the RGI in IVF, PGD, stem cell research, etc. SIL's leading scientists and specialists work in close cooperation with RGI's specialists and actively participate in research and development of both companies. RGI developed an original technique for the establishment of hESC lines from human embryos at the morula stage, which were shown to meet the NIH criteria. These lines are the basis of our bank.

Stemride International is adhered to highest moral, ethical, and scientific principals accepted by the contemporary medicine and biology. SIL is a company devoted entirely to providing the best value hESC lines to institutions conducting research in accordance with laws and regulations set forth by their governments or/and regulatory agencies.

SIL aims to establish long-lasting relationships with its customers. It is open to strategic partnership and close cooperation with research institutions having common interests in the areas of gene therapy, diagnostics, pharmacology, etc.